Biosynthetic human growth hormone in the treatment of growth hormone deficiency. 1990

J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
Lilly Research Laboratories, Indianapolis.

A total of 309 previously untreated children with growth hormone deficiency (GHD) (219 boys, 90 girls; mean age 8.4 +/- 3.9 years, range 1.5-19 years) were treated for up to 3 years in an ongoing trial designed to examine the long-term efficacy and safety of biosynthetic somatropin (rhGH). The children were treated with rhGH, 0.06 mg/kg (0.16 IU/kg) three times weekly. In the prepubertal children, the mean height velocity increased during the first year from 3.8 +/- 1.8 cm/year to 8.9 +/- 2.2 cm/year (n = 188). During the second and third years, their height velocities were 7.1 +/- 1.1 (n = 147) and 6.3 +/- 1.2 cm/year (n = 64), respectively. The height velocity SDS increased from -2.5 +/- 1.9 before treatment to 3.1 +/- 2.6 during the first year of treatment in the prepubertal children. The mean pretreatment height velocity in those with idiopathic GHD (3.8 +/- 1.6 cm/year) did not differ from that in children with organic GHD (3.8 +/- 2.3 cm/year). In addition, the height velocities during the first year of therapy did not differ significantly with respect to the aetiology of GHD. For the children who entered puberty during the study, the mean height velocity increased from 3.0 +/- 1.7 cm/year before treatment to 8.4 +/- 2.3 cm/year during the first year of rhGH therapy. In the first year, the height velocity of children with a bone age of less than 5 years (9.4 +/- 2.3 cm/year) was significantly greater than that in children with a bone age of 5-10 years (8.4 +/- 1.8 cm/year) or greater than 10 years (7.8 +/- 2.2 cm/year: p = 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D001846 Bone Development The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS. Bone Growth
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
January 1987, Srpski arhiv za celokupno lekarstvo,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
January 1989, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
February 1993, Boletin medico del Hospital Infantil de Mexico,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
October 1993, Journal of endocrinological investigation,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
January 1995, Clinical endocrinology,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
January 1987, Revista chilena de pediatria,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
January 1966, Pediatria polska,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
April 1984, The New England journal of medicine,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
January 1991, Clinical pediatrics,
J H Holcombe, and P M Conforti, and A C Wong, and R G Thompson, and M W Draper
July 1987, The Medical letter on drugs and therapeutics,
Copied contents to your clipboard!